NCT02505191View on ClinicalTrials.gov

Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Healthy
Interventions
DRUG

St. John's wort prolonged-release tablet 500 mg

DRUG

St. John's wort film coated tablets 250 mg

Trial Locations (1)

Unknown

Nuvisan GmbH, Neu-Ulm

All Listed Sponsors
lead

Max Zeller Soehne AG

INDUSTRY

NCT02505191 - Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117 | Biotech Hunter | Biotech Hunter